Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.

Moore M, Mustain M, Daniel K, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P.

Toxicol Appl Pharmacol. 1997 Jan;142(1):160-8.

PMID:
9007045
2.

Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.

Connor K, Ramamoorthy K, Moore M, Mustain M, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P.

Toxicol Appl Pharmacol. 1997 Jul;145(1):111-23.

PMID:
9221830
3.

Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.

Ramamoorthy K, Vyhlidal C, Wang F, Chen I, Safe S, McDonnell DP, Leonard LS, Gaido KW.

Toxicol Appl Pharmacol. 1997 Nov;147(1):93-100.

PMID:
9356311
4.

Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF7) cell line.

Kramer VJ, Helferich WG, Bergman A, Klasson-Wehler E, Giesy JP.

Toxicol Appl Pharmacol. 1997 Jun;144(2):363-76.

PMID:
9194421
5.

Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.

Liu H, Wormke M, Safe SH, Bjeldanes LF.

J Natl Cancer Inst. 1994 Dec 7;86(23):1758-65.

PMID:
7966413
6.

Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.

Ruh MF, Zacharewski T, Connor K, Howell J, Chen I, Safe S.

Biochem Pharmacol. 1995 Oct 26;50(9):1485-93.

PMID:
7503800
7.

Synthesis and characterization of hydroxylated polychlorinated biphenyls (PCBs) identified in human serum.

Safe S, Washburn K, Zacharewski T, Phillips T.

Chemosphere. 1995 Aug;31(4):3017-23.

PMID:
7552046
8.
9.

Assessment of PCBs and hydroxylated PCBs as potential xenoestrogens: In vitro studies based on MCF-7 cell proliferation and induction of vitellogenin in primary culture of rainbow trout hepatocytes.

Andersson PL, Blom A, Johannisson A, Pesonen M, Tysklind M, Berg AH, Olsson PE, Norrgren L.

Arch Environ Contam Toxicol. 1999 Aug;37(2):145-50.

PMID:
10398763
10.

Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity.

Bonefeld-Jørgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM.

Toxicology. 2001 Feb 14;158(3):141-53.

PMID:
11275356
13.

Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.

Lobaccaro C, Pons JF, Duchesne MJ, Auzou G, Pons M, Nique F, Teutsch G, Borgna JL.

J Med Chem. 1997 Jul 4;40(14):2217-27.

PMID:
9216841
14.

Ligand structure-dependent differences in activation of estrogen receptor alpha in human HepG2 liver and U2 osteogenic cancer cell lines.

Yoon K, Pellaroni L, Ramamoorthy K, Gaido K, Safe S.

Mol Cell Endocrinol. 2000 Apr 25;162(1-2):211-20.

PMID:
10854714
15.
16.

Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.

Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, van der Burg B.

Toxicol Sci. 1999 Mar;48(1):55-66.

PMID:
10330684
17.

Thyroid hormone-like and estrogenic activity of hydroxylated PCBs in cell culture.

Kitamura S, Jinno N, Suzuki T, Sugihara K, Ohta S, Kuroki H, Fujimoto N.

Toxicology. 2005 Mar 30;208(3):377-87.

PMID:
15695023
18.
19.
20.

In vitro estrogenicity of the catechol metabolites of selected polychlorinated biphenyls.

Garner CE, Jefferson WN, Burka LT, Matthews HB, Newbold RR.

Toxicol Appl Pharmacol. 1999 Jan 15;154(2):188-97.

PMID:
9925803

Supplemental Content

Support Center